192 related articles for article (PubMed ID: 10754493)
1. Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
Kageshita T; Hamby CV; Hirai S; Kimura T; Ono T; Ferrone S
Int J Cancer; 2000 Mar; 89(2):153-9. PubMed ID: 10754493
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
3. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
4. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
Tas F; Erturk K
Am J Dermatopathol; 2022 Nov; 44(11):799-805. PubMed ID: 35925149
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
6. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
7. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
[TBL] [Abstract][Full Text] [Related]
8. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma.
Zúñiga-Castillo M; Pereira NV; Sotto MN
Histopathology; 2018 Jun; 72(7):1189-1198. PubMed ID: 29415335
[TBL] [Abstract][Full Text] [Related]
9. Assessment of melanoma histotypes and associated patient related factors: basis for a predictive statistical model.
Haenssle HA; Hoffmann S; Buhl T; Emmert S; Schön MP; Bertsch HP; Rosenberger A
J Dtsch Dermatol Ges; 2015 Jan; 13(1):37-45. PubMed ID: 25640492
[TBL] [Abstract][Full Text] [Related]
10. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
[TBL] [Abstract][Full Text] [Related]
11. Biological behaviour of cutaneous malignant melanomas.
Søndergaard K
Pathology; 1985 Apr; 17(2):255-7. PubMed ID: 4047727
[TBL] [Abstract][Full Text] [Related]
12. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
13. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma.
Miracco C; Santopietro R; Biagioli M; Lazzi S; Nyongo A; Vatti R; Luzi P
J Cutan Pathol; 1998 May; 25(5):244-51. PubMed ID: 9696289
[TBL] [Abstract][Full Text] [Related]
15. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
16. The expression of human high molecular weight melanoma-associated antigen in acral lentiginous melanoma.
Nishi H; Inoue Y; Kageshita T; Takata M; Ihn H
Biosci Trends; 2010 Apr; 4(2):86-9. PubMed ID: 20448346
[TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma in situ: a study of nine cases.
Kwon IH; Lee JH; Cho KH
Am J Dermatopathol; 2004 Aug; 26(4):285-9. PubMed ID: 15249858
[TBL] [Abstract][Full Text] [Related]
18. [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study].
Breuninger H; Köhler C; Drepper H; Bastian B; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Hautarzt; 1994 Aug; 45(8):529-31. PubMed ID: 7960751
[TBL] [Abstract][Full Text] [Related]
19. [Acral-lentiginous melanoma: the newest subgroup of malignant melanomas of the skin].
Panizzon R; Stieger M; Schüler G; Hardmeier T
Schweiz Med Wochenschr; 1982 Apr; 112(17):612-8. PubMed ID: 7089511
[TBL] [Abstract][Full Text] [Related]
20. Unusual variants of melanoma: fact or fiction?
Sagebiel RW
Semin Oncol; 1996 Dec; 23(6):703-8. PubMed ID: 8970590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
